These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32919086)

  • 61. Unprotected intercourse in the 2 weeks prior to quick-start initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception.
    Gawron LM; Gero A; Kushner KL; Turok DK; Sanders JN
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S891-S892. PubMed ID: 31809707
    [No Abstract]   [Full Text] [Related]  

  • 62. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
    Bhattacharya SM; Jha A
    Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
    Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
    Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception.
    Lazorwitz A; Aquilante CL; Shortt JA; Sheeder J; Teal S; Gignoux CR
    Clin Transl Sci; 2021 Sep; 14(5):1713-1718. PubMed ID: 33650294
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea.
    Fox MC; Klipping C; Nguyen AM; Frenkl TL; Cruz SM; Wang Y; Korver T
    Contraception; 2019 Feb; 99(2):125-130. PubMed ID: 30439359
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immediate postpartum initiation of etonogestrel-releasing implant: A randomized controlled trial on breastfeeding impact.
    Braga GC; Ferriolli E; Quintana SM; Ferriani RA; Pfrimer K; Vieira CS
    Contraception; 2015 Dec; 92(6):536-42. PubMed ID: 26209863
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of etonogestrel implant beyond approved duration: prolonged contraceptive effectiveness.
    Ribeiro BC; Nogueira-Silva C; Afonso H; Silva PO; Reis ID
    Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):309-310. PubMed ID: 30203680
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Temporal Trends in the Uptake and Continuation of the Etonogestrel Implant in a Large Private Practice Setting.
    Howard DL; Ford A; Ceballos S; Volker KW
    J Womens Health (Larchmt); 2018 Feb; 27(2):191-195. PubMed ID: 28976797
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
    Duijkers I; Klipping C; Heger-Mahn D; Fayad GN; Frenkl TL; Cruz SM; Korver T
    Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):245-254. PubMed ID: 30203681
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?
    Tocce KM; Sheeder JL; Teal SB
    Am J Obstet Gynecol; 2012 Jun; 206(6):481.e1-7. PubMed ID: 22631865
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
    Varney SJ; Guest JF
    Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Etonogestrel contraceptive implant-associated secondary anorgasmia.
    Chapa HO; Ramirez A; Dawson D
    Contraception; 2017 Oct; 96(4):254-256. PubMed ID: 28666796
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
    Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
    Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
    Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
    Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Site necrosis at the insertion place of the single-rod subdermal contraceptive implant: report of five cases.
    Faranna MD; Pesado AC
    Eur J Contracept Reprod Health Care; 2023 Dec; 28(6):313-316. PubMed ID: 37910034
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
    Tocce K; Sheeder J; Python J; Teal SB
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acceptability of ENG-releasing subdermal implants among postpartum Brazilian young women during the COVID-19 pandemic.
    Barbieri MM; Herculano TB; Dantas Silva A; Bahamondes L; Juliato CRT; Surita FG
    Int J Gynaecol Obstet; 2021 Jul; 154(1):106-112. PubMed ID: 33656758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.